The world of medical donation can be complex and hard to navigate. Whether you are looking to donate blood, plasma, or bone marrow there are myths that often misrepresent what the process of medical donation is actually like. Sources such as cultural traditions and information found online may shape a picture in our minds that […]
The post Five Common Health Myths about Medical Donation appeared first on Medical News Bulletin.
A patient wants a more refined nose. The surgeon recommends adding cartilage. You can see why that might need explaining. Most people think about nose surgery in terms of what gets removed: a bump along the bridge, some width, a little fullness at the tip. But a nose that looks uneven or pinched after an […]
The post When Rhinoplasty Means Putting Cartilage Back appeared first on Medical News Bulletin.
ANAHEIM, Calif. — Medicare coverage is now available for the Fsyx ocular pressure adjusting pump, a device indicated to lower IOP in patients with glaucoma while they are sleeping.
The device consists of pressure-sensing goggles connected to a compact pump that counteracts IOP overnight using negative pressure. CMS reimbursement for the Fsyx ocular pressure adjusting pump (Balance Ophthalmics) became effective on Oct. 1.
{{VIDEO}}
“So many glaucoma patients are of Medicare age,” Seph Jensen, CEO of Balance Ophthalmics, told Healio at Academy 2026. “This was a necessary step to provide access to
The FDA has approved tucatinib plus trastuzumab and pertuzumab as front-line maintenance therapy for adults with unresectable, locally advanced or metastatic HER2-positive breast cancer following induction treatment.
Tucatinib (Tukysa, Seagen), an oral tyrosine kinase inhibitor, had previously been approved in 2020 as a second-line option for patients with HER2-positive breast cancer, according to a manufacturer press release.
The expanded indication is based on results of the randomized phase 3 HER2CLIMB-05 trial, which enrolled 654 patients with unresectable, locally advanced or metastatic
In the 1960s, Sir John Charnley, CBE, FRS, posited that periprosthetic joint infection was one of the most difficult complications associated with total joint replacement.
While Charnley spent his career in orthopedics whittling down the infection rate from 10% to 1.5%, infection still remains one of the major complications for TJR today.
“Whilst [PJI] may have a low incidence rate, 1% to 2%, [joint replacements are] done at such a high volume. You are talking about more than one million joint replacements,” Anoop K. Prasad, MD, PhD, a hip and knee arthroplasty attending at Harvard Medical
Chima J. Ohuabunwo, MD, MPH, a CDC-trained epidemiologist with on-the-ground experience in the largest Ebola virus outbreak in history, praised Kenya’s response this week to its first Ebola case.
“Kenya was able to pick it up early and cordon it off,” Ohuabunwo, a professor of medicine at the Morehouse School of Medicine in Atlanta, told Healio. “What the Kenyan government has done at this time, it's what we should publish and copy and follow.”
According to WHO and Kenyan health officials, a man with Ebola travelled to Kenya from the Democratic Republic of Congo on Saturday and died Monday at a
Physicians are susceptible to the same chronic diseases as our patients.
Yet we struggle to prioritize our own health and well-being while seamlessly focusing on the care of others. A contributing factor is that we may not know how to prioritize self-care in this way. Historically, medical training does not provide physicians with lifestyle medicine training and healthy behavior education. Medications and procedures get more attention; prevention, nutrition and behavior change get less.
The good news is that medical schools and residencies are increasingly recognizing the importance of
In October 2025, the FDA issued a complete response letter to Sydnexis regarding SYD-101, an investigational formulation of low-dose atropine 0.01%. Despite achieving its primary phase 3 efficacy endpoint, the eye drop was not approved.
More recently, the FDA announced that it will hold an advisory committee meeting Oct. 30 to address SYD-101, renewing the eye care community’s hope for an on-label low-dose formulation of atropine.
In a round table discussion, Healio | OSN Pediatrics/Strabismus Board Members M. Edward Wilson, MD, and Douglas R. Fredrick, MD, discussed the FDA’s shortcomings in
Cancer mortality for individuals aged under 50 years in Canada has significantly decreased for nine of the 10 deadliest malignancies since 2000.
“This is a great news story,” Darren R. Brenner, PhD, professor at Cumming School of Medicine at University of Calgary, told Healio.
However, colorectal cancer mortality has significantly increased during the same time, raising questions about whether Canada should follow the lead of other Western countries and lower the screening age to 45 years.
“It’s concerning,” Brenner said. “By not screening this younger cohort, more people every year in Canada
A randomized phase 2B trial of a novel peptide-based vaccine missed its primary endpoint, as the immunotherapy failed to significantly extend survival compared with placebo in newly diagnosed glioblastoma, according to a press release.
However, topline data showed SurVaxM (MimiVax Inc.) may have the potential to delay progression and prolong survival in a prespecified subgroup of patients aged 65 years or younger.
“For patients 65 and under, this is one of the strongest signals we have seen in newly diagnosed glioblastoma in a long time,” co-principal investigator Robert Fenstermaker, MD, chair